# Neuphoria Therapeutics Inc.: Form 6-K, filed Apr 29, 2022

- Company: [Neuphoria Therapeutics Inc.](/companies/neup.md) (CIK 1191070)
- Form: 6-K
- Filed: 2022-04-29
- Accepted by EDGAR: Apr 29, 2022, 10:02 ET
- Period: 2022-04-29
- Accession: 0000950170-22-006603
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1191070/000095017022006603/bnox-6k-app4c_q3_2022.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1191070/000095017022006603/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1191070/000095017022006603/bnox-6k-app4c_q3_2022.htm

Filed Apr 29, 2022.
Source: SEC EDGAR, the filing index for accession 0000950170-22-006603. Last ingested by Listed: Oct 24, 2026, 15:10 ET. No prices; not investment advice.